{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "cfres_id": "123209",
      "product_res_number": "Z-0490-2014",
      "event_date_initiated": "2013-10-28",
      "event_date_posted": "2013-12-17",
      "recall_status": "Terminated",
      "event_date_terminated": "2016-07-06",
      "res_event_number": "66735",
      "product_description": "Nephros Dual Stage Ultra Filter (DSU) Brochure\nDocument 60-3003\nRevisions: 0, 1, 2\n\n\nProduct Usage:  A disposable point of use water ultrafilter that delivers microbiologically pure water for washing and drinking.",
      "code_info": "Item #70-0230; 70-0231; 70-0232; 70-0234; and 70-0235  Document numbers 60-0237 (all) and 60-3003 (all)",
      "firm_fei_number": "3003337893",
      "recalling_firm": "Nephros Inc",
      "address_1": "41 Grand Ave",
      "city": "River Edge",
      "state": "NJ",
      "postal_code": "07661-1947",
      "additional_info_contact": "Ms. Eileen Sukumaran\n201-343-5202",
      "reason_for_recall": "Promotional materials for non-medical water filtration products were determined to promote claims which constitute marketing the product as a medical device.",
      "root_cause_description": "Labeling False and Misleading",
      "action": "Nephros Inc., sent  an Urgent Medical Device Recall letter dated October 29, 2013 to all affected customers via UPS 2nd Day Air.  The letter identified the affected product, problem and actions to be taken.  Customer are asked to provide a customer information list, immediately remove and discard all affected product labeling materials and any independent labeling materials they have created for the affected products.  Customers are instructed to complete and sign the attached Response Form to acknowledge receipt, understanding and compliance with the instruction.  For questions contact the Nephros representative at 201-343-5202 x 100.\n\nThe letter was also posted at : http://www.nephros.com/download/news/DSU_Recall_Letters.pdf",
      "product_quantity": "3,367 untis with affected labeling",
      "distribution_pattern": "USA Nationwide Distribution",
      "openfda": {}
    }
  ]
}